Viela Bio heads to the 2018 American College of Rheumatology / Association of Rheumatology for Health Professionals (ACR/ARHP) Annual Meeting in Chicago, 19-24 October 2018, with a late-breaking poster presentation for a novel engineered CD40L antagonist, VIB4920.
{iframe}https://www.prnewswire.com/news-releases/viela-bio-announces-late-breaking-abstract-acceptance-for-vib4920-a-novel-engineered-cd40l-antagonist-at-the-2018-acrarhp-annual-meeting-300732852.html{/iframe}